雾化吸入布地奈德治疗小儿急性喉炎的疗效分析  

Efficacy analysis of Budesonide inhalation in treatment of children with acute laryngitis

作　　者：郑元胜[1] 姜英[2] 

机构地区：[1]吉林市中心医院儿内科,吉林吉林132011 [2]吉化总医院二院物资管理科

出　　处：《中国民康医学》2017年第8期18-19,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:探讨氧气驱动雾化吸入布地奈德混悬液对治疗小儿急性喉炎的临床疗效。方法:将患有急性喉炎的患儿100例随机分为治疗组和对照组,每组各50例。两组患儿均给予抗感染、对症、保持呼吸道通畅、补液等常规治疗。治疗组患儿采用氧气驱动布地奈德混悬液雾化吸入;对照组患儿给予静脉滴注地塞米松治疗。结果:治疗后,两组患者的总有效率无差异,但显效率差异有统计学意义(P<0.05)。结论:氧气驱动布地奈德雾化吸入治疗急性喉炎患儿见效快、疗程短,可减少其全身应用糖皮质激素的不良反应,值得推广。Objective To explore clinical efficacy of oxygen-driven budesonide suspension atomization inhalation in treatment of children with acute laryngitis. Methods： 100 children with acute laryngitis were randomly divided into treatment group （n = 5 0 ） and control group （n = 50）. All the children were given anti-infection, symptomatic, keeping respiratory tract unobstructed, fluid infusion and other comprehensive treatments. Besides, the treatment group was treated with oxygen-driven Budesonide suspension atomization inhalation, while the control group was intravenously dripped with Dexamethasone. Results ： After the treatment, there was no differ-ence in the total effective rate between the two groups; however, the difference of the obvious effective rate was statistically significant （P〈0. 05）. Conclusions： Oxygen-driven budesonide atomization inhalation in the treatment of the children with acute laryngitis has quick effects and a short treatment course, can reduce the adverse effects of systemic application of glucocorticoid, and is worth promo-ting.

关 键 词：急性喉炎 布地奈德 雾化吸入 地塞米松 

分 类 号：R767.11[医药卫生—耳鼻咽喉科]